Induced Pluripotent Stem Cells Market Forecast:
Dublin, Jan. 12, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Id Pharma Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Jan. 12, 2024 (GLOBE NEWSWIRE) -- The
/PRNewswire/ -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022, By Derived Cell Type, By Application, By End-User" report has been added...
All the facts about the coronavirus. Find the latest information and answers from experts on everything COVID-19.
Equipment to produce a vaccine is installed at Unigen’s factory in Ikeda, Gifu Prefecture, in December. (Sho Ito) Japanese drug companies are moving at an “unprecedented” pace to develop COVID-19 vaccines, but their foreign rivals have already won the race. Although the government has committed hundreds of billions of yen for a game-changing medicine in the novel coronavirus pandemic, the domestic industry is just not set up for speedy vaccine development, and such projects have long been a low priority for Japanese pharmaceutical businesses. Japan plans to begin inoculating the populat...